Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
Isabel Poschke(Deutz (Germany)), Rolf Kiessling(Unknown)
Cited by 377
Related Papers
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
|Nature|1986|2.1k
Classification of current anticancer immunotherapies
|Oncotarget|2014|469
Coexpressed Catalase Protects Chimeric Antigen Receptor–Redirected T Cells as well as Bystander Cells from Oxidative Stress–Induced Loss of Antitumor Activity
|The Journal of Immunology|2015|212
Escape Mechanisms in Tumor Immunity: An Update
|Journal of Environmental Pathology Toxicology and Oncology|2002|15